APSR2026-420

Yes
Regular
Submitted
Poster Presentation
 
AP12-011
P88
 
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Rameshwar Paul * NIDCH Respiratory Medicine Dhaka Bangladesh
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
Rameshwar
Paul
rameshwarpaulsomc46@gmail.com
+8801772599031
31-40
Bangladesh
Original Research
Usefulness of Distance Saturation Product in Predicting Severity of Diffuse Parenchymal Lung Diseases
Maximum 25 words
Abstract Content
<p>The six-minute walk test (6MWT) is a practical and simple measurement of functional status that is widely used as a clinical tool. This study aimed to assess the usefulness of the distance saturation product (DSP) derived from the 6MWT in assessing disease severity in patients with DPLD, with a comparison to DLCO. </p><p><br></p><p><br></p>
<p>This cross-sectional study was conducted at the National Institute of Diseases of the Chest & Hospital from September 2023 to March 2025, following protocol approval. A total of 70 DPLD patients were enrolled in this study.  DLCO and 6MWT were performed on the same day according to ATS/ERS protocol. Data were collected using a structured questionnaire form and analyzed using SPSS 30.</p>
<p>The mean DLCO was 50.1±17.1% predicted, and median DSP was 331.3(211.5-412.7) m%. Mild, moderate, and severe reductions in DLCO were observed in 44.3%, 24.3%, and 31.4% of participants, respectively. The median DSP was found to be 381.7(328.5-454.3) in the mildly reduced DLCO group, 361.7(262.2-420.4) in the moderately reduced DLCO group, and 175.5(125.1-270.2) in the severely reduced DLCO group. The six-minute walk distance, lowest oxygen saturation during the 6MWT, and DSP were significantly lower in idiopathic pulmonary fibrosis (IPF) participants compared to non-IPF participants (p < 0.005). Spearman’s correlation analysis showed that DSP had a significant positive correlation with DLCO% predicted (rs = 0.674, p < 0.001). A DSP threshold of ≤ 289 m% demonstrated 86.4% sensitivity, 87.5% specificity, 76% positive predictive value, 93.3% negative predictive value, and 87.1% accuracy in identifying severe DPLD patients.</p>
<p>This study found that DSP is useful in differentiating severe DPLD patients from non-severe cases. A DSP ≤ 289 m% was identified as the optimal cut-off for correctly identifying severe DPLD patients.</p>
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Diffuse Parenchymal Lung Diseases, Distance Saturation Product , Diffusion Capacity for Carbon monoxide
maximum 3 keywords and no abbreviations, separated by commas
 
304